2022 annual financial data
Ironwood Pharmaceuticals 2022 Operating margin
Direct answer
Operating margin was 60.97%.
Operating income was 250,337,000 USD and net income was 175,065,000 USD.
Operating cash flow was 273,763,000 USD.
Get free Ironwood Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 410,596,000 USD
- Operating income
- 250,337,000 USD
- Net income
- 175,065,000 USD
- Operating cash flow
- 273,763,000 USD